Tamoxifen-induced tissue factor pathway inhibitor reduction: a clue for an acquired thrombophilic state?


Erman M. , Abali H. , ORAN B., Haznedaroglu I. , Canpinar H. , KİRAZLI Ş., ...Daha Fazla

ANNALS OF ONCOLOGY, cilt.15, sa.11, ss.1622-1626, 2004 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 15 Konu: 11
  • Basım Tarihi: 2004
  • Doi Numarası: 10.1093/annonc/mdh437
  • Dergi Adı: ANNALS OF ONCOLOGY
  • Sayfa Sayıları: ss.1622-1626

Özet

Background: Current understanding of hemostatic systems enables us to better explore the enigmatic pathobiology of tamoxifen (TAM)-induced thrombotic diathesis. We have therefore aimed to assess the hemostatic changes in breast cancer patients receiving TAM on an adjuvant basis.